CN116531443A - 治疗肌肤病软膏的生产方法 - Google Patents
治疗肌肤病软膏的生产方法 Download PDFInfo
- Publication number
- CN116531443A CN116531443A CN202310535133.8A CN202310535133A CN116531443A CN 116531443 A CN116531443 A CN 116531443A CN 202310535133 A CN202310535133 A CN 202310535133A CN 116531443 A CN116531443 A CN 116531443A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- powder
- pouring
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 35
- 208000017520 skin disease Diseases 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 238000002386 leaching Methods 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000003756 stirring Methods 0.000 claims abstract description 12
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 241000756943 Codonopsis Species 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 235000005412 red sage Nutrition 0.000 claims abstract description 11
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 10
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 10
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 10
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 9
- 241000218378 Magnolia Species 0.000 claims abstract description 9
- 238000001816 cooling Methods 0.000 claims abstract description 9
- 239000002893 slag Substances 0.000 claims abstract description 7
- 229940099259 vaseline Drugs 0.000 claims abstract description 7
- DSSYKIVIOFKYAU-XVKPBYJWSA-N (1s,4r)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound C1C[C@@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-XVKPBYJWSA-N 0.000 claims abstract description 6
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 6
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 6
- 239000011812 mixed powder Substances 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 238000010025 steaming Methods 0.000 claims abstract description 6
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- 238000005303 weighing Methods 0.000 claims abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims description 26
- 244000236658 Paeonia lactiflora Species 0.000 claims description 9
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 9
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 7
- 241000723346 Cinnamomum camphora Species 0.000 claims description 7
- 229960000846 camphor Drugs 0.000 claims description 6
- 229930008380 camphor Natural products 0.000 claims description 6
- 235000013717 Houttuynia Nutrition 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 20
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 210000003491 skin Anatomy 0.000 description 20
- 201000004624 Dermatitis Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 208000002874 Acne Vulgaris Diseases 0.000 description 6
- 241000207925 Leonurus Species 0.000 description 6
- 206010000496 acne Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000628997 Flos Species 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000001034 Frostbite Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000082946 Tarchonanthus camphoratus Species 0.000 description 1
- 235000005701 Tarchonanthus camphoratus Nutrition 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
一种治疗肌肤病软膏的生产方法,按质量取人参33‑37份、金银花66‑70份、白芍117‑123份、党参57‑61份、益母草252‑258份、辛夷93‑97份、丹参132‑136份、茯苓156‑160份、黄芩102‑106份、鱼腥草32‑36份,粉碎后过150‑200目筛,将混合粉末放入容器中,加入质量为2200‑2400份浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将900‑1100质量份的凡士林倒入锅内加热完全融化后再倒入中药纯粉搅拌均匀,温度保持在62℃‑68℃,再倒入98‑102份质量的樟脑粉末继续充分融化并搅拌均匀,待凉至43℃‑46℃即可分装形成软膏。本发明生产方法简单可靠易掌握,产出的药膏可以治疗多种皮肤病,适用性广,治疗效果明显。
Description
技术领域
本发明涉及一种外用药物的生产方法,尤其是一种治疗肌肤病软膏的生产方法。
背景技术
皮肤病是严重影响人民健康的常见病、多发病之一。皮肤病的形式多种多样,发病率较高,有的比较轻,一般不影响人体健康,但少数较重会使人很不舒服,甚至可以危及人的生命健康。针对不同的皮肤病,一般有对应性治疗的药物,功能性较为单一,并且有的药物治疗效果不尽人意。
发明内容
本发明的目的是提供一种治疗肌肤病软膏的生产方法,产出的药膏解决目前治疗皮肤病的药物功能单一、适用性较窄、治疗效果不够明显的缺陷。
本发明的目的是以如下方式实现的:按质量取人参33-37份、金银花66-70份、白芍117-123份、党参57-61份、益母草252-258份、辛夷93-97份、丹参132-136份、茯苓156-160份、黄芩102-106份、鱼腥草32-36份,粉碎后过150-200目筛,将混合粉末放入容器中,加入质量为2200-2400份浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣放蒸馏锅内在100℃环境下水蒸气蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将900-1100质量份的凡士林倒入锅内加热完全融化后再倒入中药纯粉搅拌均匀,温度保持在62℃-68℃,再倒入98-102份质量的樟脑粉末继续充分融化并搅拌均匀形成软膏,待凉至43℃-46℃即可分装,自然冷却后常温储存。
优选的,药物组分为人参35份、金银花68份、白芍120份、党参59份、益母草255份、辛夷95份、丹参134份、茯苓158份、黄芩104份、鱼腥草34份、樟脑100份。
粉末为150-200目;樟脑制成细粉时,需加少量的乙醇再研碎成细粉。
药物功效:止血、止痛、加速伤口愈合,可以治疗皮炎、皮癣、皮肤过敏、感染、皮肤湿疹、痔疮、青春痘、水火油烫伤、手足皴裂等。
本品通过身体外用,透皮给药的方法作用于人体后,可迅速激发人体的细胞潜能,增强机体免疫抵抗力,达到平衡身体生理机能,活血通经,补气固本,消炎止痛,加速皮肤创伤及外伤手术后愈合,促进人体微循环,加速皮肤代谢,使皮肤光泽细嫩,富有弹性。
本药物根据传统中医药理论和经验提供处方依据。祖国医学把一些外界致病因素称为邪气,把人的抵抗能力统称为正气,疾病发生与否决定于正邪双方的强度对比,如果正气充沛,能抵御邪气就不会发生疾病,反之邪气过盛就会发病,所谓正气存内邪不可干,邪之所添,其气必虚,就是这个道理。
本品所拟处方以疏通气血为主导,樟脑(香樟木)乃本方之主体,冻伤与烫伤相反,是皮肤肌肉遭受严寒空气的侵袭,受冻时间过久或严冬季节静坐少动,气血运行不畅以及气血凝滞而引起,本药亦可因病后气血运行不畅或平素气血衰弱,或过度疲劳,或暴冻着热,或暴热着冻而发生。
皮炎、皮癣、过敏、湿疹、青春痘均为皮肤局部组织代谢受阻,细菌感染、皮脂腺角化异常、炎症引发等,雄激素水平及皮脂分泌增加相关。皮脂与脱落的表皮组织混合后,形成像泥沙一样的物质塞毛孔导致青春痘、和痤疮的发作,此类症状者也多为身体内分泌紊乱,另有使用劣质或含有激素成分的化妆品也息息相关,皮癣问题除上述因素外则与脏腑及血液垃圾堆积代谢不畅有关。
手足皴裂则常于摩擦、压力、破伤浸渍等外因有关,一般多由于因热骤被寒冷风暴所逼,以致血脉阻滞,皮肤渐枯渐裂而成。
以上均为中医外科极为常见的病症,其病因正气不足,气血运行不畅,经脉阻滞等方面,基于这种认识,我们在反复实践的基础上,选用樟脑为本品软膏的君药用量最多,本品辛散走窜,药性温热,有温散止痛,疏通气血的作用,本品最早记载于《本草品汇精要》,该书谓其功效为:“主杀虫,除疥癣,疗汤火疖,敌秽气”,《本草纲目》也有“通天窍利滞气,治邪气”的记载。本品穿透力较强,虽外用皮肤吸收较快,由于不直接作用于创口,伤口刺激性较小,病人乐于接受效果显著,并有利于毒邪外出,加用凡士林或者麻油制成软膏,可使药效持久。
此方中辛夷药性辛,芳香通窍;丹参、益母草活血去瘀,协助君药疏通气血;人参、党参益气养血;白芍补血敛阴;茯苓宁心安神,用量虽小,对气血不足者至关重要,是为佐药;黄芪、金银花皆有清热解毒之功能,即可起到反佐的效果,又兼顾热毒为患的病症,协助主药更好地发挥作用;鱼腥草性辛微温,有消炎化脓解毒散热之功,作为辅料也极为理想。
中药之用,或取其性,或取其味,或取其气,本方樟脑(香樟木)用量最多,其性辛、热走窜,疏通经脉之力较强,益气养血,敛阴活血去瘀,即可扶正又可去邪,用于冻伤、创伤、炎症,疮肿,手足皴裂等病症皆为显著。
本品组方成分的药理药性总结如下:
人参
性味微甘,有特异香,微寒;成分:人参苷、人参副素;其他尚有:糖类、皂素、维生素B1、维生素B2及淀粉酶等。
功效:为强壮兴奋药,对一般虚弱者、神经衰弱、贫血、消化不良妇女病人等有效,性神经衰弱,更适用之,并做祛痰剂;补五脏,安神定魂、止惊悸、除邪气、明目、开心益智、治虚劳内伤、发汗、多梦、胃肠中冷、心下痞硬、烦悸、久用轻身延年。
2.金银花
性味:甘寒。
功效:清热解毒、消炎退肿等,金银花富含有丰富的多糖氯原酸、锰、锌、肽等活性成分,不仅可以清热解毒、消炎退肿,对抑制病原体感染,扩张血管有一定作用。
3.白芍
性味:酸,入肝经,偏于补益肝之阴血,常用于治疗血虚和面色萎黄,也可缓解眩晕,心悸,女性月经不调和崩漏带下等症状,有敛阴止汗,可治疗外感风寒,营卫不和导致的出汗或者恶风,自汗不止等,可数疏肝止痛、敛肝阴养肝血,可缓解脾虚肝旺引发的腹痛泄泻等症状。
4.党参
党参是《中国药典》收录的草药,草药来源为桔梗科植物。党参,素花党参,或川党参等的干燥根。
性味:味性平,功效补中益气、止渴,健脾益肺,养血生津,对气血不足、面色枯黄、心悸气短、经伤口渴有功效,内热消渴、滋阴补气,多用于脾肺气虚,气血双亏者。
5.益母草
性味:辛、苦;微寒;归心、肝、膀胱经。
功效:活血调经,利水消肿,清热解毒,适用于跌打损伤,疮疽肿毒,皮肤瘾疹,活血化瘀,止痛消肿,清毒等作用。
6.辛夷
别名:迎春、木笔花、毛辛夷、姜朴花,来源于木兰科植物玉花的花蕾。
性味:辛,温,无毒,归肺胃经。
功效:散风寒,通鼻窍,多用于外感风寒、头痛、鼻塞、浊涕长流等症。
7.丹参
别名:大红袍、血神、红根、紫丹参、雪山根、红丹参。
性味:苦,性,微寒,归心肝二经。
功效:活血去瘀、通经止痛、清心除烦、养血消瘀,多用于胸痹心痛、脘腹肋痛、心痛不眠、月经不调、痛经闭经,疮疡肿痛者。
8.茯苓
性味:性平,归心经脾经;
功效:用途广泛,可以和各种草药配伍,不管寒温风湿,诸疾均有其显著作用,具有利水渗湿、健脾和胃、养心安神的功效。
9.黄芩
性味:味苦,归心肺胆大肠经;
功效:清热燥湿,泻火解毒,凉血止血,用于湿温、暑温、胸闷呕恶、泻痢、肺热咳嗽、痈肿疮毒、黄疸等,肤枯,能降血压、动脉硬化、头痛失眠、肠胃炎、心悸苦闷等。
10.鱼腥草
别名:十药、芥药、鸡虱药、重药。
性味:辛,微温,气臊臭。
功效:利水解毒,消炎化脓,用于中耳炎、湿疹、散热解毒等。
11.樟脑
是樟树的树干、枝、叶,经蒸馏以后而形成的颗粒状物。
性味:有特异芳香气,味苦,性平。
功效:解热、解痉,镇痛、皮肤诱异、兴奋中枢神经等。舒筋活络,消肿止痛,跌打扭伤,风湿骨痛,无名肿毒及炎症等,对治疗手足耳部位的2度冻疮,皮肤擦伤肿胀,瘙痒,疼痛有真菌感染,止痒止痒,伤口愈合等均有显著作用。
本药膏使用方法:外用药膏治疗皮肤炎症,瘙痒,皮癣,外伤,取适量药膏均匀地涂抹患者患处大5倍面积的皮肤上,若是全身性皮肤问题可以把此药膏均匀涂抹全身表皮,轻柔且适度的力度按摩至吸收即可,每天一次~两次,一般3天左右患处有明星好转效果;对较轻的皮肤问题,如轻度的皮炎、湿疹、痤疮、青春痘、皮癣,一般10天左右基本可以恢复;中度问题的一般20天左右可以恢复;中重度问题的一般一个月基本恢复,且皮肤会更加细腻光滑富有弹性。
此药膏与皮肤接触后,通过按摩刺激可以有效促进新陈代谢,激活皮肤细胞潜能,进一步挖掘和调动了皮肤的修复功能,大大增强皮肤的免疫力和防御力,此药膏可以给伤损的皮肤组织提供营养使之快速自愈,修复敏感肌,通经活络使皮肤充满活力。
临床应用:近几年使用药膏治疗皮肤过敏炎症,包括湿疹、痤疮、瘙痒、外伤、牛皮癣共计465例,其中女性、儿童和青少年居多,治愈率在95%以上。
女性占114例,一般是面部过敏(化妆品及激素类)、湿疹109例,1-2度皮肤创伤98例,痤疮76例,牛皮癣68例;治愈率均在95%以上。
本发明的生产方法可以切实可行地生产出治疗肌肤病软膏,生产方法简单可靠易掌握,所产出的药膏可以治疗多种皮肤病,适用性广,治疗效果明显。
具体实施方式
实施例
取人参35g、金银花68g、白芍120g、党参59g、益母草255g、辛夷95g、丹参134g、茯苓158g、黄芩104g、鱼腥草34g,粉碎后过200目筛,将混合粉末放入容器中,加入质量为2300g浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣放蒸馏锅内在100℃环境下水蒸气蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将1000g凡士林倒入锅内完全融化后再倒入中药纯粉搅拌均匀,温度保持在65℃,再倒入100g樟脑粉末继续充分融化并搅拌均匀形成软膏,待凉至43℃-46℃即可分装,自然冷却后常温储存。
实施例
取人参3.7kg、金银花7kg、白芍12.3kg、党参6.1kg、益母草25.8kg、辛夷9.7kg、丹参13.6kg、茯苓16kg、黄芩10.6kg、鱼腥草3.6kg,粉碎后过150目筛,将混合粉末放入容器中,加入质量为240kg浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣放蒸馏锅内在100℃环境下水蒸气蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将110kg凡士林倒入锅内完全融化后再倒入中药纯粉搅拌均匀,温度保持在68℃,再倒入10.2kg樟脑粉末继续充分融化并搅拌均匀形成软膏,待凉至43℃-46℃即可分装,自然冷却后常温储存。
实施例
取人参330g、金银花660g、白芍1.17kg、党参570g、益母草2.52kg、辛夷930g、丹参1.32kg、茯苓1.56kg、黄芩1.02kg、鱼腥草320g,粉碎后过150目筛,将混合粉末放入容器中,加入质量为22kg浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣放蒸馏锅内在100℃环境下水蒸气蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将9kg凡士林倒入锅内完全融化后再倒入中药纯粉搅拌均匀,温度保持在62℃,再倒入980g樟脑粉末继续充分融化并搅拌均匀形成软膏,待凉至43℃-46℃即可分装,自然冷却后常温储存。
Claims (3)
1.一种治疗肌肤病软膏的生产方法,其特征在于:按质量取人参33-37份、金银花66-70份、白芍117-123份、党参57-61份、益母草252-258份、辛夷93-97份、丹参132-136份、茯苓156-160份、黄芩102-106份、鱼腥草32-36份,粉碎后过150-200目筛,将混合粉末放入容器中,加入质量为2200-2400份浓度为95%的乙醇中浸泡15天,放置阴凉处每天搅拌一次,将浸出液倒出留存,把剩余中药粉渣放蒸馏锅内在100℃环境下水蒸气蒸2小时得到蒸馏液,将浸出液和蒸馏液分别去除液体得中药纯粉;将900-1100质量份的凡士林倒入锅内加热完全融化后再倒入中药纯粉搅拌均匀,温度保持在62℃-68℃,再倒入98-102份质量的樟脑粉末继续充分融化并搅拌均匀形成软膏,待凉至43℃-46℃即可分装,自然冷却后常温储存。
2.根据权利要求1所述的治疗肌肤病软膏的生产方法,其特征在于:药物组分为人参35份、金银花68份、白芍120份、党参59份、益母草255份、辛夷95份、丹参134份、茯苓158份、黄芩104份、鱼腥草34份、樟脑100份。
3.根据权利要求1所述的治疗肌肤病软膏的生产方法,其特征在于:粉末为150-200目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310535133.8A CN116531443A (zh) | 2023-05-12 | 2023-05-12 | 治疗肌肤病软膏的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310535133.8A CN116531443A (zh) | 2023-05-12 | 2023-05-12 | 治疗肌肤病软膏的生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116531443A true CN116531443A (zh) | 2023-08-04 |
Family
ID=87446700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310535133.8A Pending CN116531443A (zh) | 2023-05-12 | 2023-05-12 | 治疗肌肤病软膏的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116531443A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106983790A (zh) * | 2017-04-20 | 2017-07-28 | 高洁瑜 | 一种杀灭和抑制癌细胞的自然生物降解素及其制备方法 |
CN108743712A (zh) * | 2018-09-05 | 2018-11-06 | 吉林省满草堂健康管理集团有限公司 | 一种提高儿童免疫力的外用中药膏剂及其制备方法 |
-
2023
- 2023-05-12 CN CN202310535133.8A patent/CN116531443A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106983790A (zh) * | 2017-04-20 | 2017-07-28 | 高洁瑜 | 一种杀灭和抑制癌细胞的自然生物降解素及其制备方法 |
CN108743712A (zh) * | 2018-09-05 | 2018-11-06 | 吉林省满草堂健康管理集团有限公司 | 一种提高儿童免疫力的外用中药膏剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
彭成等: "《中国临床药物大辞典 中药成方制剂:全2卷》", vol. 2018, 31 August 2018, 中国医药科技出版社, pages: 619 * |
王海燕;: "迪银片联合佑三软膏治疗寻常型银屑病", 山东医药, no. 06, 25 February 2008 (2008-02-25), pages 97 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316146B (zh) | 一种麻醉用中药制剂 | |
CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
CN103877247B (zh) | 用于治疗褥疮的药物及其制备方法 | |
CN102579708A (zh) | 一种壮阳补肾健肝肺的中药配方 | |
CN103893670B (zh) | 一种治疗心脑血管病的中药药丸 | |
CN104435866A (zh) | 一种用于大面积创伤后止血的中药组合物 | |
CN104623600A (zh) | 一种治疗末梢神经炎的中药及其制备方法 | |
CN103751708A (zh) | 一种治疗下肢静脉曲张的中药外用制剂及其制备方法 | |
CN116531443A (zh) | 治疗肌肤病软膏的生产方法 | |
CN112957441A (zh) | 一种祛风除湿、温通经络、活血止痛的外用药膜涂膜剂及其制备方法 | |
CN105561270A (zh) | 一种外敷止痛中草药及其制备方法 | |
CN102626471B (zh) | 一种具有防敏脱敏、修复再生作用的中药组合物 | |
CN105250758A (zh) | 一种治疗糖尿病的中药组合物 | |
CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
CN111617153A (zh) | 一种用于补虚劳、壮元阳的中药组合物及其制剂和应用 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN101518579B (zh) | 一种稳压疏通药及制备工艺 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104547549A (zh) | 一种防治放射性皮炎的中药组合物 | |
CN108126161A (zh) | 一种治疗高血压的中草药及其制备方法和应用 | |
CN103341054B (zh) | 一种治疗心脑血管疾病的中药制剂及制备方法 | |
CN108159276A (zh) | 一种熏蒸液及其制备方法和使用方法 | |
CN106853188A (zh) | 一种用于胆道出血症的中药组合物及其制备方法 | |
CN105770081A (zh) | 用于促进脑出血手术后愈合的组合物制剂及其制备方法 | |
CN115590936A (zh) | 一种保健药酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |